408 related articles for article (PubMed ID: 28439797)
21. Detection of beta-catenin mutations in paraffin-embedded sporadic desmoid-type fibromatosis by mutation-specific restriction enzyme digestion (MSRED): an ancillary diagnostic tool.
Amary MF; Pauwels P; Meulemans E; Roemen GM; Islam L; Idowu B; Bousdras K; Diss TC; O'Donnell P; Flanagan AM
Am J Surg Pathol; 2007 Sep; 31(9):1299-309. PubMed ID: 17721184
[TBL] [Abstract][Full Text] [Related]
22. Event-free survival in Desmoid-Type fibromatosis (DTF): A pre-post comparison of upfront surgery versus wait-and-see approach.
Ruspi L; Cananzi FCM; Sicoli F; Samà L; Renne SL; Marrari A; Gennaro N; Colombo P; Cozzaglio L; Politi LS; Bertuzzi A; Quagliuolo V
Eur J Surg Oncol; 2021 May; 47(5):1196-1200. PubMed ID: 32847695
[TBL] [Abstract][Full Text] [Related]
23. Desmoid-type fibromatosis of the head and neck in children: A changing situation.
Paul A; Blouin MJ; Minard-Colin V; Galmiche L; Coulomb A; Corradini N; Boutroux H; Van den Abbeele T; Leboulanger N; Denoyelle F; Garabedian EN; Couloigner V; Orbach D
Int J Pediatr Otorhinolaryngol; 2019 Aug; 123():33-37. PubMed ID: 31059930
[TBL] [Abstract][Full Text] [Related]
24. Clinical results of active surveillance for extra-abdominal desmoid-type fibromatosis.
Sakai T; Nishida Y; Ito K; Ikuta K; Urakawa H; Koike H; Imagama S
Cancer Med; 2023 Mar; 12(5):5245-5254. PubMed ID: 36210645
[TBL] [Abstract][Full Text] [Related]
25. Desmoid Fibromatosis: Management in an Era of Increasing Options.
Ratan R; Roland CL; Bishop AJ
Curr Oncol Rep; 2021 Mar; 23(4):41. PubMed ID: 33719012
[TBL] [Abstract][Full Text] [Related]
26. Immunohistochemical staining with non-phospho β-catenin as a diagnostic and prognostic tool of COX-2 inhibitor therapy for patients with extra-peritoneal desmoid-type fibromatosis.
Sakai T; Nishida Y; Hamada S; Koike H; Ikuta K; Ota T; Ishiguro N
Diagn Pathol; 2017 Aug; 12(1):66. PubMed ID: 28851389
[TBL] [Abstract][Full Text] [Related]
27. An update on the management of sporadic desmoid-type fibromatosis: a European Consensus Initiative between Sarcoma PAtients EuroNet (SPAEN) and European Organization for Research and Treatment of Cancer (EORTC)/Soft Tissue and Bone Sarcoma Group (STBSG).
Kasper B; Baumgarten C; Garcia J; Bonvalot S; Haas R; Haller F; Hohenberger P; Penel N; Messiou C; van der Graaf WT; Gronchi A;
Ann Oncol; 2017 Oct; 28(10):2399-2408. PubMed ID: 28961825
[TBL] [Abstract][Full Text] [Related]
28. Management of Desmoids.
Grignol VP; Pollock R; Howard JH
Surg Clin North Am; 2016 Oct; 96(5):1015-30. PubMed ID: 27542640
[TBL] [Abstract][Full Text] [Related]
29. [Desmoid tumors in children: current strategy].
Oudot C; Defachelles AS; Minard-Colin V; Olschwang S; Fourcade L; Helfre S; Orbach D
Bull Cancer; 2013 May; 100(5):518-28. PubMed ID: 23695183
[TBL] [Abstract][Full Text] [Related]
30. Desmoid tumors: need for an individualized approach.
de Bree E; Keus R; Melissas J; Tsiftsis D; van Coevorden F
Expert Rev Anticancer Ther; 2009 Apr; 9(4):525-35. PubMed ID: 19374605
[TBL] [Abstract][Full Text] [Related]
31. Desmoid fibromatosis in children and adolescents: a conservative approach to management.
Honeyman JN; Theilen TM; Knowles MA; McGlynn MM; Hameed M; Meyers P; Crago AM; La Quaglia MP
J Pediatr Surg; 2013 Jan; 48(1):62-6. PubMed ID: 23331794
[TBL] [Abstract][Full Text] [Related]
32. Desmoid tumor: from surgical extirpation to molecular dissection.
Lazar AJ; Hajibashi S; Lev D
Curr Opin Oncol; 2009 Jul; 21(4):352-9. PubMed ID: 19436199
[TBL] [Abstract][Full Text] [Related]
33. Molecular Pathogenesis of Sporadic Desmoid Tumours and Its Implications for Novel Therapies: A Systematised Narrative Review.
McLean TD; Duchi S; Di Bella C
Target Oncol; 2022 May; 17(3):223-252. PubMed ID: 35446005
[TBL] [Abstract][Full Text] [Related]
34. Wait-and-see policy as a first-line management for extra-abdominal desmoid tumors.
Briand S; Barbier O; Biau D; Bertrand-Vasseur A; Larousserie F; Anract P; Gouin F
J Bone Joint Surg Am; 2014 Apr; 96(8):631-8. PubMed ID: 24740659
[TBL] [Abstract][Full Text] [Related]
35. [Intraabdominal desmoid tumors in familial adenomatous polyposis].
Galletto P; Leoz ML; Castells A; Balaguer F
Gastroenterol Hepatol; 2013 Nov; 36(9):580-6. PubMed ID: 23541808
[TBL] [Abstract][Full Text] [Related]
36. Nationwide trends in the current management of desmoid (aggressive) fibromatosis.
Eastley NC; Hennig IM; Esler CP; Ashford RU
Clin Oncol (R Coll Radiol); 2015 Jun; 27(6):362-8. PubMed ID: 25736277
[TBL] [Abstract][Full Text] [Related]
37. Desmoid-type fibromatosis: imaging features and course.
Okuda M; Yoshida K; Kobayashi S; Gabata T
Skeletal Radiol; 2023 Jul; 52(7):1293-1303. PubMed ID: 36646850
[TBL] [Abstract][Full Text] [Related]
38. Desmoid Tumors: Current Perspective and Treatment.
Mangla A; Agarwal N; Schwartz G
Curr Treat Options Oncol; 2024 Feb; 25(2):161-175. PubMed ID: 38270798
[TBL] [Abstract][Full Text] [Related]
39. Is immunohistochemical staining for β-catenin the definitive pathological diagnostic tool for desmoid-type fibromatosis? A multi-institutional study.
Koike H; Nishida Y; Kohno K; Shimoyama Y; Motoi T; Hamada S; Kawai A; Ogose A; Ozaki T; Kunisada T; Matsumoto Y; Matsunobu T; Ae K; Gokita T; Sakai T; Shimizu K; Ishiguro N
Hum Pathol; 2019 Feb; 84():155-163. PubMed ID: 30292627
[TBL] [Abstract][Full Text] [Related]
40. Systemic Chemotherapies Retain Antitumor Activity in Desmoid Tumors Independent of Specific Mutations in CTNNB1 or APC: A Multi-institutional Retrospective Study.
Nathenson MJ; Hu J; Ratan R; Somaiah N; Hsu R; DeMaria PJ; Catoe HW; Pang A; Subhawong TK; Amini B; Sweet K; Feister K; Malik K; Jagannathan J; Braschi-Amirfarzan M; Sheren J; Caldas Y; Moreno Tellez C; Rosenberg AE; Lazar AJ; Maki RG; Benedetto P; Cohen J; Trent JC; Ravi V; Patel S; Wilky BA
Clin Cancer Res; 2022 Sep; 28(18):4092-4104. PubMed ID: 35180772
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
